Overview

Update
Total Equity Funding
$2.87M in 3 Rounds from 8 Investors
Most Recent Funding
Venture on December 5, 2014 / Undisclosed Amount
Headquarters:
London, England
Description:
Synthace produces bio-based chemical products through the application of synthetic biology.
Founders:
, ,
Categories:
Biotechnology
Website:
http://synthace.com
Social:

Company Details

Update

Synthace is the UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace harnesses the ability of micro-organisms to produce complex, high-value chemical and biological products from sustainable and renewable feedstocks. In addition to equity funding, the company has received a £500,000 Technology Strategy Board award entitled ‘Rapid Engineering of Cellular Factories’, in collaboration with University College London and University of Manchester. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is initially focused towards applications in the production of specialty chemicals.

Funding Rounds (3) - $2.87M

Update
DateAmount / RoundValuationLead InvestorInvestors
Dec, 2014undisclosed amount / Venture1
Sep, 2013£1.3M / Seed2
Apr, 2013$900k / Seed5

Current Team (8)

Update

Offices/Locations (1)

Update
  • HQ

    The London Bioscience Innovation Centre

    2 Royal College Street

    London, England NW1 0NH

    United Kingdom

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos

Portions of this content provided by